SKIN CANCER

This small, early study is testing a flexible treatment schedule for people with advanced melanoma that has a specific genetic change (BRAF mutation). It combines two drugs that target the cancer's growth signals with an immunotherapy drug that helps the immune system fight the c…

This early-stage study aims to find the highest safe dose of a new drug called XL888 when given with two existing melanoma drugs (vemurafenib and cobimetinib). It involves 26 adults with advanced, BRAF-mutated melanoma that cannot be removed by surgery. The main goals are to dete…

This study is testing whether adding a precise, high-dose radiation treatment (SBRT) to a two-drug immunotherapy combination works better for controlling advanced Merkel cell carcinoma. It will compare the standard immunotherapy pair (nivolumab and ipilimumab) against the same dr…

This study is testing new non-invasive imaging techniques to better examine skin lesions and normal skin. Researchers are collecting images of various skin spots along with small, targeted biopsies to compare results. The long-term goal is to develop technology that improves earl…

This study is testing whether a cream containing the drug sirolimus can prevent new facial skin cancers in people who have received an organ transplant. Organ transplant recipients have a much higher risk of developing skin cancer. The trial involves 146 participants who will app…

This study aims to understand how satisfied patients are with their appearance and scar results after skin cancer surgery. Researchers will survey 3,000 adults who have had surgery for skin cancers like melanoma, basal cell, or squamous cell carcinoma. The goal is to learn how su…

This is a small pilot study to see if a community education session can help people learn more about skin cancer and check their skin more often. About 35 adults in Bensonhurst, Brooklyn will attend a session led by a community health worker. Researchers will use surveys to track…